Author Correction: Reclassifying neurodegenerative diseases

Pablo Villoslada^{1

2}, Ricardo Baeza-Yates^{3

4}, Joseph C Masdeu^{5

6}

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA. pvillos@stanford.edu.
² Department of Neurosciences, Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain. pvillos@stanford.edu.
³ Khoury College of Computer Sciences, Northeastern University at Silicon Valley, San Jose, CA, USA.
⁴ Department of Information and Communication Technologies, Pompeu Fabra University, Barcelona, Spain.
⁵ Nantz National Alzheimer Center, Department of Neurology, Houston Methodist Neurological and Research Institutes, Houston, TX, USA.
⁶ Department of Neurology, Weill Cornell Medicine, New York, NY, USA.

Published Erratum

Pablo Villoslada et al. Nat Biomed Eng. 2020 Dec.

. 2020 Dec;4(12):1221.

doi: 10.1038/s41551-020-00628-2.

Pablo Villoslada^{1

2}, Ricardo Baeza-Yates^{3

4}, Joseph C Masdeu^{5

6}

¹ Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA. pvillos@stanford.edu.
² Department of Neurosciences, Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain. pvillos@stanford.edu.
³ Khoury College of Computer Sciences, Northeastern University at Silicon Valley, San Jose, CA, USA.
⁴ Department of Information and Communication Technologies, Pompeu Fabra University, Barcelona, Spain.
⁵ Nantz National Alzheimer Center, Department of Neurology, Houston Methodist Neurological and Research Institutes, Houston, TX, USA.
⁶ Department of Neurology, Weill Cornell Medicine, New York, NY, USA.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Reclassifying neurodegenerative diseases.
Villoslada P, Baeza-Yates R, Masdeu JC. Villoslada P, et al. Nat Biomed Eng. 2020 Aug;4(8):759-760. doi: 10.1038/s41551-020-0600-3. Nat Biomed Eng. 2020. PMID: 32747833 No abstract available.